A photo from open sources
New UK data suggests risk the development of cancer in humans during life by 2027 will rise to 50 percent – this means that every second can get sick. IN this is largely due to the fact that people live everything longer. Figures published by british charity cancer research organization, Cancer Research UK, point to that in the next 15 years every fifty people out of a hundred in at some point in life, cancer will be diagnosed. For comparison, in In 2010, this probability was estimated as 44 to 100. For the same data, the risk of developing cancer in women over the same period will increase from 40 up to 44 to 100. The main component of this statistic is age – The main factor influencing the likelihood of developing cancer. Long life means a high risk of cancer. IN developed countries, more people reach the age when they become prone to developing cancer. CEO Cancer Research UK Garpal Kumar states that these data allow “look into the future.” According to him, the increase in duration life is a big plus, however it also means that many people will be diagnosed with malignant neoplasms. Be that as it may, thanks to research, diagnosis and treatment cancers are constantly improving, therefore, although the risk of getting sick the chances of recovery are increasing. According to experts in the next fifteen years will grow most significantly number of cancers such as prostate cancer glands, colon cancer and melanoma. Prostate cancer This type of cancer is a huge problem: incidence grows, while there is no reliable way to highlight particularly threatening life cases. “Prostate cancer needs thorough study, “says Cancer Research UK expert on this varieties of the disease, Professor Malcolm Mason. By his there’s still a lot to be done regarding this disease. to find out. With progressive aging, the population will more and more cases of prostate cancer are being reported. Mason reports: “Over the past forty years, the number of cases of cancer the prostate tripled, and three quarters of the patients – men over 65 years. “Still, there is hope – in the publication Molecular Cancer Research encouraging article published. It talks about finding The Mayo Clinic at Florida has a special enzyme. It is called PRSS3 or mesotrypsin; it is he who perhaps stimulates development this kind of cancer. The clinic believes that this information help to more accurately diagnose and better treat this disease. Yet one promising research area is staff Cancer Research UK. They study a protein called Microseminoprotein Beta (MSMB) the likelihood of the patient having prostate cancer. It is assumed that this protein will become a more advanced tumor marker than the prostatic specific antigen (PSA) currently in use. TO For example, in an article published by PLoS ONE in 2010, scientists from the cancer research organization reported: “isolated from MSMB urine samples are much more effective than PSA differentiate cancer aggressiveness on the Glisson scale. “(High Gleason scores are associated with poor prognosis diseases approx. mixednews.ru) According to Mason, this discovery will selectively identify men with a high probability the presence of the disease, and save the rest from having to go all subsequent diagnostic steps. Still, further research in order for this diagnostic method to find mass application. Bowel cancer Thanks to research, the diagnosis and treatment of bowel cancer has come a long way. Scientists have demonstrated how flexible sigmoidoscopy can reduce mortality from bowel cancer and its incidence. In 2011 year in the Journal of the National Cancer Institute was published material about this diagnostic method. According to the study, the total the incidence of the disease decreased by 18 percent, mortality – by 22 percent. Efficiency experimental method is confirmed by a decrease in incidence by 31 percent, in some cases by 46 percent. And mortality among the study participants a new method decreased by 38 percent. Cancer Research UK also carried out a long-term study lasting 16 years. It showed a decrease incidence by a third, and mortality by 43 percent among patients who were followed by flexible sigmoidoscopy. The study was supervised by a cancer expert. intestines by professor Wendy Atkin. She said: “Our study showed that thanks to flexible sigmoidoscopy we were able for the first time so noticeably reduce the incidence of bowel cancer, as well as reduce deaths. “Atkins describes his work as an “excellent example” of the benefits that research brings. She added: “In no other way would we have succeeded so to advance in the development of new methods of treatment, evaluate them effectiveness and determine which categories of patients can help this treatment. “Melanoma Cancer Research results UK and similar organizations around the world give hope to patients with far-reaching cases of melanoma, predicting the emergence of new treatment methods. It is important that work continues on improving disease prevention methods. Most Melanoma cases caused by prolonged exposure to the sun ultraviolet radiation, prolonged lying in sun loungers. One of recently published articles contains information on called sun rays genetic changes. Research Underway in adjacent areas, revealed how melanoma cells “avoid attention” of immunity and how cancer develops resistance to chemotherapy.
A life
